These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 38356031)

  • 1. Excipients for Novel Inhaled Dosage Forms: An Overview.
    Yousry C; Goyal M; Gupta V
    AAPS PharmSciTech; 2024 Feb; 25(2):36. PubMed ID: 38356031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation strategy and use of excipients in pulmonary drug delivery.
    Pilcer G; Amighi K
    Int J Pharm; 2010 Jun; 392(1-2):1-19. PubMed ID: 20223286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Present Situation and Future Progress of Inhaled Lung Cancer Therapy: Necessity of Inhaled Formulations with Drug Delivery Functions.
    Okuda T; Okamoto H
    Chem Pharm Bull (Tokyo); 2020; 68(7):589-602. PubMed ID: 32611996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhalation aspects of therapeutic aerosols.
    Leach CL
    Toxicol Pathol; 2007 Jan; 35(1):23-6. PubMed ID: 17325969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug delivery to the lungs: challenges and opportunities.
    Newman SP
    Ther Deliv; 2017 Jul; 8(8):647-661. PubMed ID: 28730933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Back to the future: inhaled drug products.
    Hickey AJ
    J Pharm Sci; 2013 Apr; 102(4):1165-72. PubMed ID: 23381932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of inhalation therapy in chronic obstructive pulmonary disease and asthma.
    Pavia D
    Respirology; 1997; 2 Suppl 1():S5-10. PubMed ID: 9400688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.
    Brocklebank D; Ram F; Wright J; Barry P; Cates C; Davies L; Douglas G; Muers M; Smith D; White J
    Health Technol Assess; 2001; 5(26):1-149. PubMed ID: 11701099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chinese expert consensus on standardized inhaler device application in stable chronic airway diseases (2023)].
    Inhalation Therapy and Respiratory Rehabilitation Group, Respiratory Equipment Committee of China Association of Medical Equipment
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 Nov; 46(11):1055-1067. PubMed ID: 37914418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary drug delivery: novel pharmaceutical technologies breathe new life into the lungs.
    Nanjwade BK; Adichwal SA; Gaikwad KR; Parikh KA; Manvi FV
    PDA J Pharm Sci Technol; 2011; 65(5):513-34. PubMed ID: 22293840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inhaled medication in pediatrics].
    Sapet A; Oudyi M; Dubus JC
    Rev Pneumol Clin; 2013 Aug; 69(4):198-206. PubMed ID: 23850269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug combinations for inhalation: Current products and future development addressing disease control and patient compliance.
    Banat H; Ambrus R; Csóka I
    Int J Pharm; 2023 Aug; 643():123070. PubMed ID: 37230369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guidelines for devices and choices.
    Everard ML
    J Aerosol Med; 2001; 14 Suppl 1():S59-64. PubMed ID: 11424895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimizing drug delivery in COPD: The role of inhaler devices.
    Rogliani P; Calzetta L; Coppola A; Cavalli F; Ora J; Puxeddu E; Matera MG; Cazzola M
    Respir Med; 2017 Mar; 124():6-14. PubMed ID: 28284323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhalation delivery of complex drugs-the next steps.
    de Kruijf W; Ehrhardt C
    Curr Opin Pharmacol; 2017 Oct; 36():52-57. PubMed ID: 28846876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary drug delivery systems: recent developments and prospects.
    Courrier HM; Butz N; Vandamme TF
    Crit Rev Ther Drug Carrier Syst; 2002; 19(4-5):425-98. PubMed ID: 12661699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dry powder inhalers for optimal drug delivery.
    Newman SP
    Expert Opin Biol Ther; 2004 Jan; 4(1):23-33. PubMed ID: 14680466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delivery technology of inhaled therapy for asthma and COPD.
    Chow MYT; Pan HW; Lam JKW
    Adv Pharmacol; 2023; 98():273-311. PubMed ID: 37524490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of co-milling techniques for the production of high dose dry powder inhaler formulation.
    Lau M; Young PM; Traini D
    Drug Dev Ind Pharm; 2017 Aug; 43(8):1229-1238. PubMed ID: 28367654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.